# Direct Instruction Language for Learning in Autism Spectrum Disorder

> **NCT02483910** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 137 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Moderate Language Delay

## Interventions

- **BEHAVIORAL:** Direct Instruction-Language for Learning (DI-LL) via telehealth (e.g., Zoom or WebEx)
- **BEHAVIORAL:** Standard of care delivered via telehealth (e.g., Zoom or WebEx)

## Key facts

- **NCT ID:** NCT02483910
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2020-11-24
- **Final completion:** 2020-11-24
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2021-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02483910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02483910, "Direct Instruction Language for Learning in Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02483910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*